Hydroxypropyl beta cyclodextrin: a water-replacement agent or a surfactant upon spray freeze-drying of IgG with enhanced stability and aerosolization

References

• Costantino HR, Firouzabadian L, Wu C, et al. Protein spray freeze drying. 2. Effect of formulation variables on particle size and stability. J Pharm Sci. 2002;91(2):388–395.
   PubMed Web of Science ®Google Scholar
• Abdul-Fattah AM, Kalonia DS, Pikal MJ. The challenge of drying method selection for protein pharmaceuticals: product quality implications. J Pharm Sci. 2007;96(8):1886–1916.
   PubMed Web of Science ®Google Scholar
• Wang W. Lyophilization and development of solid protein pharmaceuticals. Int J Pharm. 2000;203(1–2):1–60.
   PubMed Web of Science ®Google Scholar
• Bhatnagar BS, Bogner RH, Pikal MJ. Protein stability during freezing: separation of stresses and mechanisms of protein stabilization. Pharm Dev Technol. 2007;12(5):505–523.
   PubMed Web of Science ®Google Scholar
• Serno T, Geidobler R, Winter G. Protein stabilization by cyclodextrins in the liquid and dried state. Adv Drug Deliv Rev. 2011;63(13):1086–1106.
   PubMed Web of Science ®Google Scholar
• Srichana T, Suedee R, Reanmongkol W. Cyclodextrin as a potential drug carrier in salbutamol dry powder aerosols: the in-vitro deposition and toxicity studies of the complexes. Respir Med. 2001;95(6):513–519.
   PubMed Web of Science ®Google Scholar
• Dufour G, Bigazzi W, Wong N, et al. Interest of cyclodextrins in spray-dried microparticles formulation for sustained pulmonary delivery of budesonide. Int J Pharm. 2015;495(2):869–878.
   PubMedGoogle Scholar
• Tavornvipas S, Tajiri S, Hirayama F, et al. Effects of hydrophilic cyclodextrins on aggregation of recombinant human growth hormone. Pharm Res. 2004;21(12):2369–2376.
   PubMed Web of Science ®Google Scholar
• Shao Z, Krishnamoorthy R, Mitra AK. Cyclodextrins as nasal absorption promoters of insulin: mechanistic evaluations. Pharm Res. 1992;09(9):1157–1163.
   Google Scholar
• Taneri F, Güneri T, Aigner Z, et al. Improvement in the physicochemical properties of ketoconazole through complexation with cyclodextrin derivatives. J Incl Macrocycl Chem. 2002;44(1/4):257–260.
   Web of Science ®Google Scholar
• Millqvist-Fureby A, Malmsten M, Bergenståhl B. Surface characterisation of freeze-dried protein/carbohydrate mixtures. Int J Parm. 1999;191(2):103–114.
   PubMed Web of Science ®Google Scholar
• Iwai J, Ogawa N, Nagase H, et al. Effects of various cyclodextrins on the stability of freeze-dried lactate dehydrogenase. J Pharm Sci. 2007;96(11):3140–3143.
   PubMed Web of Science ®Google Scholar
• Carpenter JF, Pikal MJ, Chang BS, et al. Rational design of stable lyophilized protein formulations: some practical advice. Pharm Res. 1997;14(8):969–975.
   PubMed Web of Science ®Google Scholar
• Amini Pouya M, Daneshmand B, Aghababaie S, et al. Spray-freeze drying: a suitable method for aerosol delivery of antibodies in the presence of trehalose and cyclodextrins. AAPS PharmSciTech. 2018;19(5):2247–2254.
   PubMed Web of Science ®Google Scholar
• Hong P, Koza S, Bouvier ES. Size-exclusion chromatography for the analysis of protein biotherapeutics and their aggregates. J Liq Chromatogr Relat Technol. 2012;35(20):2923–2950.
   PubMed Web of Science ®Google Scholar
• Gallagher SR. One-dimensional SDS gel electrophoresis of proteins. Curr Protoc Mol Biol. 2006;75(1):10–12.
   Google Scholar
• Ung KT, Rao N, Weers JG, et al. In Vitro Assessment of dose delivery performance of dry powders for inhalation. Aerosol Sci Technol. 2014;48(10):1099–1110.
   Web of Science ®Google Scholar
• Schule S, Friess W, Bechtold-Peters K, et al. Conformational analysis of protein secondary structure during spray-drying of antibody/mannitol formulations. Eur J Parm Biopharm. 2007;65(1):1–9.
   PubMed Web of Science ®Google Scholar
• Kane C, O’Neil K, Conk M, et al. Inhalation delivery of protein therapeutics. Inflamm Allergy Drug Targets. 2013;12(2):81–87. Apr
   PubMedGoogle Scholar
• Gikanga B, Turok R, Hui A, et al. Manufacturing of high-concentration monoclonal antibody formulations via spray drying-the road to manufacturing scale. PDA J Pharm Sci Technol. 2015;69(1):59–73.
   PubMedGoogle Scholar
• Sonner C, Maa YF, Lee G. Spray-freeze-drying for protein powder preparation: particle characterization and a case study with trypsinogen stability. J Pharm Sci. 2002;91(10):2122–2139.
   PubMed Web of Science ®Google Scholar
• Carpenter JF, Kendrick BS, Chang BS, et al. Inhibition of stress-induced aggregation of protein therapeutics. Meth Enzymol. 1999;309:236–255.
   PubMed Web of Science ®Google Scholar
• Kerwin BA. Polysorbates 20 and 80 used in the formulation of protein biotherapeutics: structure and degradation pathways. J Pharm Sci. 2008;97(8):2924–2935.
   PubMed Web of Science ®Google Scholar
• Wang W, Wang YJ, Wang DQ. Dual effects of Tween 80 on protein stability. Int J Pharm. 2008;347(1–2):31–38.
   PubMed Web of Science ®Google Scholar
• Branchu S, Forbes RT, York P, et al. Hydroxypropyl-beta-cyclodextrin inhibits spray-drying-induced inactivation of beta-galactosidase. J Pharm Sci. 1999;88(9):905–911.
   PubMed Web of Science ®Google Scholar
• Brewster ME, Hora MS, Simpkins JW, et al. Use of 2-hydroxypropyl-beta-cyclodextrin as a solubilizing and stabilizing excipient for protein drugs. Pharm Res. 1991;08 (6):792–795.
   Google Scholar
• Castellanos IJ, Flores G, Griebenow K. Effect of cyclodextrins on alpha-chymotrypsin stability and loading in PLGA microspheres upon S/O/W encapsulation. J Pharm Sci. 2006;95(4):849–858.
   PubMed Web of Science ®Google Scholar
• Chang L, Shepherd D, Sun J, et al. Mechanism of protein stabilization by sugars during freeze-drying and storage: native structure preservation, specific interaction, and/or immobilization in a glassy matrix? J Pharm Sci. 2005;94(7):1427–1444.
   PubMed Web of Science ®Google Scholar
• Allison SD, Chang B, Randolph TW, et al. Hydrogen bonding between sugar and protein is responsible for inhibition of dehydration-induced protein unfolding. Arch Biochem Biophys. 1999;365(2):289–298.
   PubMed Web of Science ®Google Scholar
• Wang W, Singh S, Zeng DL, et al. Antibody structure, instability, and formulation. J Pharm Sci. 2007;96(1):1–26.
   PubMed Web of Science ®Google Scholar
• Anchordoquy TJ, Izutsu KI, Randolph TW, et al. Maintenance of quaternary structure in the frozen state stabilizes lactate dehydrogenase during freeze-drying. Arch Biochem Biophys. 2001;390(1):35–41.
   PubMed Web of Science ®Google Scholar
• Santagapita PR, Brizuela LG, Mazzobre MF, et al. Structure/function relationships of several biopolymers as related to invertase stability in dehydrated systems. Biomacromolecules. 2008;9(2):741–747.
   PubMed Web of Science ®Google Scholar
• Yoshida A, Arima H, Uekama K, et al. Pharmaceutical evaluation of hydroxyalkyl ethers of β-cyclodextrins. Int J Pharm. 1988;46(3):217–222.
   Google Scholar
• Ken-Ichi I, Sumie Y, Tadao T. Stabilization of β-galactosidase by amphiphilic additives during freeze-drying. Int J Pharm. 1993;90(3):187–194.
   Google Scholar
• Izutsu K, Yoshioka S, Kojima S. Increased stabilizing effects of amphiphilic excipients on freeze-drying of lactate dehydrogenase (LDH) by dispersion into sugar matrices. Pharm Res. 1995;12(6):838–843.
   PubMed Web of Science ®Google Scholar
• Chefson A, Zhao J, Auclair K. Sugar-mediated lyoprotection of purified human CYP3A4 and CYP2D6. J Biotechnol. 2007;130(4):436–440.
   PubMed Web of Science ®Google Scholar
• Ramezani V, Vatanara A, Najafabadi AR, et al. A comparative study on the physicochemical and biological stability of IgG1 and monoclonal antibodies during spray drying process. Daru. 2014;22(1):31–31.
   PubMedGoogle Scholar
• Griebenow K, Klibanov A. Lyophilization-Induced Reversible Changes in the Secondary Structure of Proteins. Proc Natl Acad Sci. 1995;92(24):10969–10976.
   PubMed Web of Science ®Google Scholar
• Ali ME, Lamprecht A. Spray freeze drying for dry powder inhalation of nanoparticles. Eur J Pharm Biopharm. 2014;87(3):510–517.
   PubMed Web of Science ®Google Scholar
• Elversson J, Millqvist-Fureby A, Alderborn G, et al. Droplet and particle size relationship and shell thickness of inhalable lactose particles during spray drying. J Pharm Sci. 2003;92(4):900–910.
   PubMed Web of Science ®Google Scholar
• Saluja V, Amorij JP, Kapteyn JC, et al. A comparison between spray drying and spray freeze drying to produce an influenza subunit vaccine powder for inhalation. J Controlled Release. 2010;144(2):127–133.
   PubMed Web of Science ®Google Scholar
• Ramezani V, Vatanara A, Seyedabadi M, et al. Application of cyclodextrins in antibody microparticles: potentials for antibody protection in spray drying. Drug Dev Ind Pharm. 2017;43(7):1103–1111.
   PubMed Web of Science ®Google Scholar
• Schule S, Schulz-Fademrecht T, Garidel P, et al. Stabilization of IgG1 in spray-dried powders for inhalation. Eur J Pharm Biopharm. 2008;69(3):793–807.
   PubMed Web of Science ®Google Scholar
• Hooton JC, Jones MD, Price R. Predicting the behavior of novel sugar carriers for dry powder inhaler formulations via the use of a cohesive-adhesive force balance approach. J Pharm Sci. 2006;95(6):1288–1297.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Huang Z, Zhang X, et al. Low density, good flowability cyclodextrin-raffinose binary carrier for dry powder inhaler: anti-hygroscopicity and aerosolization performance enhancement. Expert Opin Drug Deliv. 2018;15(5):443–457.
   PubMed Web of Science ®Google Scholar
• Hamishehkar H, Rahimpour Y, Javadzadeh Y. The role of carrier in dry powder inhaler. Drug Discov Today. 2012;3:39–66.
   Google Scholar